All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Host Cell Type | Target | scFv Clone | CAR Construction | CAR Cell Type | Inquiry & Datasheet |
CARJ-LX034 | Anti-CD19&CD22 h(4-1BB-CD3ζ) CAR, Jurkat Cell | T lymphocyte | CD19&CD22 | scFv-4-1BB-CD3ζ | |||
CARJ-LX048 | Anti-CD19&CD22 h(4-1BB-CD3-T2A-tEGFR (Suicide switch)) CAR, Jurkat Cell | T lymphocyte | CD19&CD22 | scFv-4-1BB-CD3-T2A-tEGFR (Suicide switch) | |||
CARJ-LX049 | Anti-CD19&CD22 h(4-1BB-CD3-T2A-RQR8 (Ritiximab suicide switch)) CAR, Jurkat Cell | T lymphocyte | CD19&CD22 | scFv-4-1BB-CD3-T2A-RQR8 (Ritiximab suicide switch) |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION